|
Vbi Vaccines Inc (NASDAQ: VBIV) |
|
Vbi Vaccines Inc
VBIV's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Vbi Vaccines Inc growth rates, revenue grew
by 150.31 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 119
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.34 %
Vbi Vaccines Inc net loss decreased from $-28 millions, to $-18 millions in I. Quarter 2024,
• More on VBIV's Growth
|
|
Vbi Vaccines Inc realized a net loss in trailing twelve months.
Vbi Vaccines Inc realized cash reduction of $ -1.13 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.16.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.
• More on VBIV's Valuation
|
|
|
|
|
Vbi Vaccines Inc realized net loss in trailing twelve months.
Vbi Vaccines Inc realized cash outflow of $ -1.13per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.16.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.
• More on VBIV's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com